Advisory - Health Canada advises consumers not to use weight loss products containing ephedrine and caffeine

Advisory - Health Canada advises consumers not to use weight loss products containing ephedrine and caffeine Health Canada is advising consumers not to use any combination of ephedrine and caffeine because of the risk of serious and possibly fatal effects. Two particular products pose potential health risks, WestPharm Hydro-Lean capsules, and a combination of 4Ever Fit ephedrine and caffeine pills.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Cargill Health & Food Technologies to Speak at 2nd Annual World Obesity and Weight Loss Congress Pam Stauffer, marketing programs manager, and Paul Paslaski, market development director, will be featured speakers at the 2nd Annual World Obesity and Weight Loss Congress, speaking on healthy ingredient marketing and the benefits of co-branding. Cargill Health & Food Technologies to Speak at 2nd Annual World Obesity and Weight Loss Congress Pam Stauffer, marketing programs manager, and Paul Paslaski, market development director, will be featured speakers at the 2nd Annual World Obesity and Weight Loss Congress, speaking on healthy ingredient marketing and the benefits of co-branding. Cargill Health & Food Technologies to Speak at 2nd Annual World Obesity and Weight Loss Congress Pam Stauffer, marketing programs manager, and Paul Paslaski, market development director, will be featured speakers at the 2nd Annual World Obesity and Weight Loss Congress, speaking on healthy ingredient marketing and the benefits of co-branding. Cargill Health & Food Technologies to Speak at 2nd Annual World Obesity and Weight Loss Congress Pam Stauffer, marketing programs manager, and Paul Paslaski, market development director, will be featured speakers at the 2nd Annual World Obesity and Weight Loss Congress, speaking on healthy ingredient marketing and the benefits of co-branding. Cargill Health & Food Technologies to Speak at 2nd Annual World Obesity and Weight Loss Congress Pam Stauffer, marketing programs manager, and Paul Paslaski, market development director, will be featured speakers at the 2nd Annual World Obesity and Weight Loss Congress, speaking on healthy ingredient marketing and the benefits of co-branding. Sabinsa Executive to Address Weight Management at the 2005 World Obesity & Weight Loss Congress Vladimir Badmaev, M.D., Ph.D., vice president of medical and scientific affairs at Sabinsa Corporation, will present "The Role of Lean Body Mass in Successful Weight Management" at the World Obesity and Weight Loss Congress in Washington D.C. on Tuesday, September 13, 2005 from 3:30 - 4:15 p.m. Sabinsa Executive to Address Weight Management at the 2005 World Obesity & Weight Loss Congress Vladimir Badmaev, M.D., Ph.D., vice president of medical and scientific affairs at Sabinsa Corporation, will present "The Role of Lean Body Mass in Successful Weight Management" at the World Obesity and Weight Loss Congress in Washington D.C. on Tuesday, September 13, 2005 from 3:30 - 4:15 p.m. Sabinsa Executive to Address Weight Management at the 2005 World Obesity & Weight Loss Congress Vladimir Badmaev, M.D., Ph.D., vice president of medical and scientific affairs at Sabinsa Corporation, will present "The Role of Lean Body Mass in Successful Weight Management" at the World Obesity and Weight Loss Congress in Washington D.C. on Tuesday, September 13, 2005 from 3:30 - 4:15 p.m. Sabinsa Executive to Address Weight Management at the 2005 World Obesity & Weight Loss Congress Vladimir Badmaev, M.D., Ph.D., vice president of medical and scientific affairs at Sabinsa Corporation, will present "The Role of Lean Body Mass in Successful Weight Management" at the World Obesity and Weight Loss Congress in Washington D.C. on Tuesday, September 13, 2005 from 3:30 - 4:15 p.m. Sabinsa Executive to Address Weight Management at the 2005 World Obesity & Weight Loss Congress Vladimir Badmaev, M.D., Ph.D., vice president of medical and scientific affairs at Sabinsa Corporation, will present "The Role of Lean Body Mass in Successful Weight Management" at the World Obesity and Weight Loss Congress in Washington D.C. on Tuesday, September 13, 2005 from 3:30 - 4:15 p.m. NMI's Trend #4: Weighty Issues: Adult and Childhood Obesity are Key Consumer Drivers According to NMI’s 2004 Health & Wellness Trends Database, weight-related issues are a key driver to a significant portion of American consumers. Fifty percent of all consumers control their weight for appearance while 43% manage their weight for their health. In total, almost 60% of U.S. adults are managing their weight for either reason. NMI's Trend #4: Weighty Issues: Adult and Childhood Obesity are Key Consumer Drivers According to NMI’s 2004 Health & Wellness Trends Database, weight-related issues are a key driver to a significant portion of American consumers. Fifty percent of all consumers control their weight for appearance while 43% manage their weight for their health. In total, almost 60% of U.S. adults are managing their weight for either reason. NMI's Trend #4: Weighty Issues: Adult and Childhood Obesity are Key Consumer Drivers According to NMI’s 2004 Health & Wellness Trends Database, weight-related issues are a key driver to a significant portion of American consumers. Fifty percent of all consumers control their weight for appearance while 43% manage their weight for their health. In total, almost 60% of U.S. adults are managing their weight for either reason. Dr. Richard Visser to Present Childhood Obesity Research at World Obesity and Weight Loss Congress Dr. Richard Visser will discuss the issue of childhood obesity and present his clinical research at the 2005 World Obesity and Weight Loss Congress, September 12-14, 2005 in Washington, DC. Dr. Richard Visser to Present Childhood Obesity Research at World Obesity and Weight Loss Congress Dr. Richard Visser will discuss the issue of childhood obesity and present his clinical research at the 2005 World Obesity and Weight Loss Congress, September 12-14, 2005 in Washington, DC. Dr. Richard Visser to Present Childhood Obesity Research at World Obesity and Weight Loss Congress Dr. Richard Visser will discuss the issue of childhood obesity and present his clinical research at the 2005 World Obesity and Weight Loss Congress, September 12-14, 2005 in Washington, DC. Dr. Richard Visser to Present Childhood Obesity Research at World Obesity and Weight Loss Congress Dr. Richard Visser will discuss the issue of childhood obesity and present his clinical research at the 2005 World Obesity and Weight Loss Congress, September 12-14, 2005 in Washington, DC. Dr. Richard Visser to Present Childhood Obesity Research at World Obesity and Weight Loss Congress Dr. Richard Visser will discuss the issue of childhood obesity and present his clinical research at the 2005 World Obesity and Weight Loss Congress, September 12-14, 2005 in Washington, DC. Humanetics Corporation Presents 7-Keto® at 2nd Annual World Obesity and Weight Loss Congress Dr. John Zenk, Chief Medical Officer of Humanetics Corporation, is a featured speaker at the 2nd Annual World Obesity and Weight Loss Congress, taking place September 12-14, 2005 in Washington, D.C. Humanetics Corporation Presents 7-Keto® at 2nd Annual World Obesity and Weight Loss Congress Dr. John Zenk, Chief Medical Officer of Humanetics Corporation, is a featured speaker at the 2nd Annual World Obesity and Weight Loss Congress, taking place September 12-14, 2005 in Washington, D.C. Humanetics Corporation Presents 7-Keto® at 2nd Annual World Obesity and Weight Loss Congress Dr. John Zenk, Chief Medical Officer of Humanetics Corporation, is a featured speaker at the 2nd Annual World Obesity and Weight Loss Congress, taking place September 12-14, 2005 in Washington, D.C. Humanetics Corporation Presents 7-Keto® at 2nd Annual World Obesity and Weight Loss Congress Dr. John Zenk, Chief Medical Officer of Humanetics Corporation, is a featured speaker at the 2nd Annual World Obesity and Weight Loss Congress, taking place September 12-14, 2005 in Washington, D.C. Humanetics Corporation Presents 7-Keto® at 2nd Annual World Obesity and Weight Loss Congress Dr. John Zenk, Chief Medical Officer of Humanetics Corporation, is a featured speaker at the 2nd Annual World Obesity and Weight Loss Congress, taking place September 12-14, 2005 in Washington, D.C. Advisory - Health Canada advises consumers not to use certain herbal weight loss products from China Health Canada is warning consumers not to use certain weight loss products from China because they have been found to contain sibutramine, a prescription medication that should only be taken under medical supervision - product are RS Slim & Fit, Xianting Qianzhisu, Menze Qianweisu, Shou Shen Dan-Xiao Nan Wan, Kartien Slimming Herbs Capsules, and Kartien Trimming Formula. Advisory - Health Canada advises consumers not to use certain herbal weight loss products from China Health Canada is warning consumers not to use certain weight loss products from China because they have been found to contain sibutramine, a prescription medication that should only be taken under medical supervision - product are RS Slim & Fit, Xianting Qianzhisu, Menze Qianweisu, Shou Shen Dan-Xiao Nan Wan, Kartien Slimming Herbs Capsules, and Kartien Trimming Formula. Advisory - Health Canada advises consumers not to use certain herbal weight loss products from China Health Canada is warning consumers not to use certain weight loss products from China because they have been found to contain sibutramine, a prescription medication that should only be taken under medical supervision - product are RS Slim & Fit, Xianting Qianzhisu, Menze Qianweisu, Shou Shen Dan-Xiao Nan Wan, Kartien Slimming Herbs Capsules, and Kartien Trimming Formula. Major Weight-Loss Marketers Pay $3 Million Sellers making questionable weight-loss and fat-loss claims to peddle skin gels and diet supplements will pay $3 million to settle Federal Trade Commission charges that their deceptive claims violated federal law, with the sttlements barring unsubstantiated claims in the future and bars the marketers from misrepresenting studies or endorsements. Major Weight-Loss Marketers Pay $3 Million Sellers making questionable weight-loss and fat-loss claims to peddle skin gels and diet supplements will pay $3 million to settle Federal Trade Commission charges that their deceptive claims violated federal law, with the sttlements barring unsubstantiated claims in the future and bars the marketers from misrepresenting studies or endorsements. Major Weight-Loss Marketers Pay $3 Million Sellers making questionable weight-loss and fat-loss claims to peddle skin gels and diet supplements will pay $3 million to settle Federal Trade Commission charges that their deceptive claims violated federal law, with the sttlements barring unsubstantiated claims in the future and bars the marketers from misrepresenting studies or endorsements. Major Weight-Loss Marketers Pay $3 Million Sellers making questionable weight-loss and fat-loss claims to peddle skin gels and diet supplements will pay $3 million to settle Federal Trade Commission charges that their deceptive claims violated federal law, with the sttlements barring unsubstantiated claims in the future and bars the marketers from misrepresenting studies or endorsements. Major Weight-Loss Marketers Pay $3 Million Sellers making questionable weight-loss and fat-loss claims to peddle skin gels and diet supplements will pay $3 million to settle Federal Trade Commission charges that their deceptive claims violated federal law, with the sttlements barring unsubstantiated claims in the future and bars the marketers from misrepresenting studies or endorsements. Major Weight-Loss Marketers Pay $3 Million Sellers making questionable weight-loss and fat-loss claims to peddle skin gels and diet supplements will pay $3 million to settle Federal Trade Commission charges that their deceptive claims violated federal law, with the sttlements barring unsubstantiated claims in the future and bars the marketers from misrepresenting studies or endorsements. Stephen Adelé, Challenges Local Denver Police Department to Shape Up and Lose Weight Adelé challenges the local Denver Police Department to get in “tip-top shape”… and offers them $1 for every pound of bodyfat they lose. Force responds by losing 2244 pounds of body fat over 12 weeks. Stephen Adelé, Challenges Local Denver Police Department to Shape Up and Lose Weight Adelé challenges the local Denver Police Department to get in “tip-top shape”… and offers them $1 for every pound of bodyfat they lose. Force responds by losing 2244 pounds of body fat over 12 weeks. Stephen Adelé, Challenges Local Denver Police Department to Shape Up and Lose Weight Adelé challenges the local Denver Police Department to get in “tip-top shape”… and offers them $1 for every pound of bodyfat they lose. Force responds by losing 2244 pounds of body fat over 12 weeks. Patent Issued for SLIMALUMA Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same." Patent Issued for SLIMALUMA Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same." Patent Issued for SLIMALUMA Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same." Patent Issued for SLIMALUMA Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same." InterHealth Names Pathway Exclusive Distributor for Australia and New Zealand Company announces the appointment of Pathway International Pty Ltd as its exclusive distributor for the Australian and New Zealand markets. InterHealth Names Pathway Exclusive Distributor for Australia and New Zealand Company announces the appointment of Pathway International Pty Ltd as its exclusive distributor for the Australian and New Zealand markets. InterHealth Names Pathway Exclusive Distributor for Australia and New Zealand Company announces the appointment of Pathway International Pty Ltd as its exclusive distributor for the Australian and New Zealand markets. InterHealth Names Pathway Exclusive Distributor for Australia and New Zealand Company announces the appointment of Pathway International Pty Ltd as its exclusive distributor for the Australian and New Zealand markets. InterHealth Names Pathway Exclusive Distributor for Australia and New Zealand Company announces the appointment of Pathway International Pty Ltd as its exclusive distributor for the Australian and New Zealand markets. InterHealth Names Pathway Exclusive Distributor for Australia and New Zealand Company announces the appointment of Pathway International Pty Ltd as its exclusive distributor for the Australian and New Zealand markets. ORAFTI to Unveil Key Research Showing Beneo(TM) Oligofructose Can Help Control Obesity Company will attend this year’s HIE in Frankfurt, Germany, to present results of a recently published human volunteer study, demonstrating that when Beneo(TM) oligofructose is incorporated into the diet, it can limit hunger feelings and food intake. ORAFTI to Unveil Key Research Showing Beneo(TM) Oligofructose Can Help Control Obesity Company will attend this year’s HIE in Frankfurt, Germany, to present results of a recently published human volunteer study, demonstrating that when Beneo(TM) oligofructose is incorporated into the diet, it can limit hunger feelings and food intake. ORAFTI to Unveil Key Research Showing Beneo(TM) Oligofructose Can Help Control Obesity Company will attend this year’s HIE in Frankfurt, Germany, to present results of a recently published human volunteer study, demonstrating that when Beneo(TM) oligofructose is incorporated into the diet, it can limit hunger feelings and food intake. ORAFTI to Unveil Key Research Showing Beneo(TM) Oligofructose Can Help Control Obesity Company will attend this year’s HIE in Frankfurt, Germany, to present results of a recently published human volunteer study, demonstrating that when Beneo(TM) oligofructose is incorporated into the diet, it can limit hunger feelings and food intake. ORAFTI to Unveil Key Research Showing Beneo(TM) Oligofructose Can Help Control Obesity Company will attend this year’s HIE in Frankfurt, Germany, to present results of a recently published human volunteer study, demonstrating that when Beneo(TM) oligofructose is incorporated into the diet, it can limit hunger feelings and food intake. FTC Reaches “New Year’s” Resolutions with Four Major Weight-Control Pill Marketers Marketers of four products –Xenadrine EFX, CortiSlim, TrimSpa, and One-A-Day WeightSmart – have settled with the FTC, surrendered cash and other assets worth at least $25 million, and agreed to limit their future advertising claims. FTC Reaches “New Year’s” Resolutions with Four Major Weight-Control Pill Marketers Marketers of four products –Xenadrine EFX, CortiSlim, TrimSpa, and One-A-Day WeightSmart – have settled with the FTC, surrendered cash and other assets worth at least $25 million, and agreed to limit their future advertising claims. FTC Reaches “New Year’s” Resolutions with Four Major Weight-Control Pill Marketers Marketers of four products –Xenadrine EFX, CortiSlim, TrimSpa, and One-A-Day WeightSmart – have settled with the FTC, surrendered cash and other assets worth at least $25 million, and agreed to limit their future advertising claims. Humanetics Corporation & Reliv International Announce New Partnership With The Slimplicity(TM) Weight Loss Program Humanetics Corporation & Reliv International recently announced their new partnership with the launch of the Slimplicity(TM) Weight Loss System, including Slimplicity(TM) Accelerator capsules Humanetics Corporation & Reliv International Announce New Partnership With The Slimplicity(TM) Weight Loss Program Humanetics Corporation & Reliv International recently announced their new partnership with the launch of the Slimplicity(TM) Weight Loss System, including Slimplicity(TM) Accelerator capsules Humanetics Corporation & Reliv International Announce New Partnership With The Slimplicity(TM) Weight Loss Program Humanetics Corporation & Reliv International recently announced their new partnership with the launch of the Slimplicity(TM) Weight Loss System, including Slimplicity(TM) Accelerator capsules Humanetics Corporation & Reliv International Announce New Partnership With The Slimplicity(TM) Weight Loss Program Humanetics Corporation & Reliv International recently announced their new partnership with the launch of the Slimplicity(TM) Weight Loss System, including Slimplicity(TM) Accelerator capsules Humanetics Corporation & Reliv International Announce New Partnership With The Slimplicity(TM) Weight Loss Program Humanetics Corporation & Reliv International recently announced their new partnership with the launch of the Slimplicity(TM) Weight Loss System, including Slimplicity(TM) Accelerator capsules Fabuless™ Weight Management from DSM Fabuless™ Weight Management from DSM Fabuless™ Weight Management from DSM Fabuless™ Weight Management from DSM Fabuless™ Weight Management from DSM Sweet music for Fabuless Sweet music for Fabuless Sweet music for Fabuless Sweet music for Fabuless Sweet music for Fabuless New US Appointment Reflects Fabuless Success New US Appointment Reflects Fabuless Success Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	OTTAWA, May 23 /CNW Telbec/ - Health Canada is advising consumers not to use any combination of ephedrine and caffeine because of the risk of serious and possibly fatal effects. Two particular products pose potential health risks, WestPharm Hydro-Lean capsules, and a combination of 4Ever Fit ephedrine and caffeine pills. Canadians suffering from heart conditions, high blood pressure and diabetes are among those particularly at risk. WestPharm Hydro-Lean has not been assessed by Health Canada for safety, effectiveness or quality and is not authorized for sale in Canada. It is, however, distributed through the Internet and may have been brought into Canada either by personal importation or other means. Health Canada is working with the Canada Border Services Agency to prohibit further importation of this product. The 4Ever Fit ephedrine and caffeine pills are packaged in separate bottles, but are sold together in a Convenience Pack. Ephedrine and caffeine are authorized in Canada as separate products, but they are not authorized to be sold or taken in combination. 4Ever Fit Convenience Pack has been recalled from retail stores by the Canadian distributor, 4Ever Fit, due to the risk of serious and potentially fatal effects. When used in combination with caffeine and other stimulants, ephedrine has caused reported adverse events ranging from dizziness, tremors, headaches and irregularities in heart rate to seizures, psychosis, heart attacks and stroke. One report of an adverse reaction suspected to be related to the use of Hydro-Lean has been reported to Health Canada. The symptoms in this case included an elevated heart rate and general discomfort. All individuals who have used WestPharm Hydro-Lean or the ephedrine and caffeine tablets in the 4Ever Fit Convenience Pack, or any other products containing ephedrine and stimulants such as caffeine, should stop consuming them. Such products should not be used for weight loss, increased energy, body building or any other purpose. Consumers who believe they have experienced adverse effects from taking these products should consult their health care practitioner. Both ephedra and ephedrine are authorized by Health Canada for use only as a nasal decongestant in over-the-counter cold products. All such authorized products carry an eight-digit Drug Identification Number (DIN) or Natural Product Number (NPN) on the label and should be used only as directed, for short periods of time. Currently, the maximum allowable dosage for ephedrine is 8 mg in a single dose or 32 mg per day. The maximum allowable dosage for ephedra is 400 mg in a single dose or 1,600 mg per day. Consumers should avoid using unauthorized products that contain ephedra or ephedrine in combination with caffeine or other stimulants because of the health risk. As a source of ephedrine, the label on these products may list: ma huang, Chinese ephedra, ma huang extract, ephedra, Ephedra Sinica, ephedra extract, ephedra herb powder, Sida Cordifolia or epitonin. As a source of caffeine or other stimulants, the label on these products may list: green tea, guarana, yerba mate, cola nut and yohimbine. To obtain further information about ephedra/ephedrine, please consult the following document on the Health Canada website: Ephedra/ephedrine - Frequently Asked Questions. Health Canada stresses that ordering health products online without professional medical advice and monitoring can pose a number of health risks. Before taking any health products, consumers are urged to discuss the issue with their health care practitioner. To report finding WestPharm Hydro-Lean, the Combination Pack of 4Ever Fit ephedrine and caffeine pills, or any other unauthorized products combining ephedrine and a stimulant, such as caffeine, on the Canadian market, please contact the Health Products and Food Branch Inspectorate at: 1-800-267-9675. To report a suspected adverse reaction to WestPharm Hydro-Lean, the 4Ever Fit Combination Pack of ephedrine and caffeine tablets or any other health product, please contact the Canadian Adverse Drug Reaction Monitoring Program (CADRMP) of Health Canada by one of the following methods: Telephone: 1-866-234-2345 Fax: 1-866-678-6789 CADRMP Marketed Health Products Directorate Health Protection Building, Tunney's Pasture, AL 0701C Ottawa, Ontario K1A 0K9 Email: cadrmp@hc-sc.gc.ca Public inquiries about issues raised in this advisory should be directed to Health Canada at (613) 957-2991 or toll free at 1-866-225-0709.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software